{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:56:56Z","timestamp":1778511416257,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","award":["HLRC-9705"],"award-info":[{"award-number":["HLRC-9705"]}],"id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Non-alcoholic steatohepatitis (NASH) has become a global medical problem. Currently, there is no approved pharmacologic treatment for this condition. Previous studies have suggested that in the pathogenesis of this disease, regulatory pathways associated with de novo lipogenesis and \u03b2-oxidation pathways genes are misregulated. Capparis spinosa (CS) belongs to the family of Capparidaceae and is a traditional plant used to treat various diseases, particularly dyslipidemia. The compounds and extracts of this plant in In vivo and in vitro studies resulted in a reduction in lipid profiles and glucose. However, the mechanism of these effects remains unknown. This study aimed to evaluate the effects of (CS) fruit extract on NASH compared to fenofibrate and explored the related molecular mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the rats (n\u2009=\u200940) model of NASH, biochemical and histopathological examinations showed that liver steatosis, inflammation, and hepatic fibrosis were markedly attenuated in response to CS and fenofibrate interventions. At the molecular level, CS treatment down-regulated sterol regulatory element-binding protein-1c (SREBP-1c) (p\u2009&lt;\u20090.001), acetyl-CoA carboxylase (ACC) (p\u2009&lt;\u20090.001), and up-regulated Carnitine palmitoyltransferase I (CPT1) expression (p\u2009&lt;\u20090.001). In conclusion, CS has favorable therapeutic effects for NASH, which was associated with ameliorating steatosis and fibrosis via regulation of the DNL and \u03b2-oxidation pathway genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13104-022-06205-x","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T07:02:59Z","timestamp":1664780579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Capparis spinosa improves non-alcoholic steatohepatitis through down-regulating SREBP-1c and a PPAR\u03b1-independent pathway in high-fat diet-fed rats"],"prefix":"10.1186","volume":"15","author":[{"given":"Rasoul","family":"Akbari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Yaghooti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Taha","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laya Sadat","family":"Khorsandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-8099","authenticated-orcid":false,"given":"Narges","family":"Mohammadtaghvaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"6","key":"6205_CR1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/gast.2002.33573","volume":"122","author":"JM Clark","year":"2002","unstructured":"Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122(6):1649\u201357. https:\/\/doi.org\/10.1053\/gast.2002.33573.","journal-title":"Gastroenterology"},{"key":"6205_CR2","unstructured":"Ludwig J, Viggiano TR, Mcgill DB, Oh B, editors. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings; 1980."},{"issue":"5","key":"6205_CR3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","volume":"5","author":"M Gaggini","year":"2013","unstructured":"Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5(5):1544\u201360. https:\/\/doi.org\/10.3390\/nu5051544.","journal-title":"Nutrients"},{"issue":"15","key":"6205_CR4","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2174\/13816128113199990486","volume":"20","author":"D Guo","year":"2014","unstructured":"Guo D, Hlavin Bell E, Mischel P, Chakravarti A. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des. 2014;20(15):2619\u201326. https:\/\/doi.org\/10.2174\/13816128113199990486.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"6205_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3892\/ijmm.21.4.507","volume":"21","author":"M Kohjima","year":"2008","unstructured":"Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med. 2008;21(4):507\u201311. https:\/\/doi.org\/10.3892\/ijmm.21.4.507.","journal-title":"Int J Mol Med"},{"issue":"9343","key":"6205_CR6","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/S0140-6736(02)11395-X","volume":"360","author":"L Dubuquoy","year":"2002","unstructured":"Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auwerx J, Desreumaux P. Role of peroxisome proliferator-activated receptor \u03b3 and retinoid X receptor heterodimer in hepatogastroenterological diseases. The Lancet. 2002;360(9343):1410\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(02)11395-X.","journal-title":"The Lancet"},{"issue":"7203","key":"6205_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07202","volume":"454","author":"SJ Bensinger","year":"2008","unstructured":"Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454(7203):470. https:\/\/doi.org\/10.1038\/nature07202.","journal-title":"Nature"},{"key":"6205_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijbiomac.2016.11.049","volume":"95","author":"F Mazarei","year":"2017","unstructured":"Mazarei F, Jooyandeh H, Noshad M, Hojjati M. Polysaccharide of caper (Capparis spinosa L.) leaf: extraction optimization, antioxidant potential and antimicrobial activity. Intern J Biol Macromol. 2017;95:224\u201331. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.11.049.","journal-title":"Intern J Biol Macromol"},{"key":"6205_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jff.2017.05.001","volume":"35","author":"A Mollica","year":"2017","unstructured":"Mollica A, Zengin G, Locatelli M, Stefanucci A, Mocan A, Macedonio G, et al. Anti-diabetic and anti-hyperlipidemic properties of Capparis spinosa L.: in vivo and in vitro evaluation of its nutraceutical potential. J Funct Foods. 2017;35:32\u201342. https:\/\/doi.org\/10.1016\/j.jff.2017.05.001.","journal-title":"J Funct Foods"},{"issue":"11","key":"6205_CR10","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/ptr.5684","volume":"30","author":"SF Nabavi","year":"2016","unstructured":"Nabavi SF, Maggi F, Daglia M, Habtemariam S, Rastrelli L, Nabavi SM. Pharmacological effects of capparis spinosa L. Phytother Res. 2016;30(11):1733\u201344. https:\/\/doi.org\/10.1002\/ptr.5684.","journal-title":"Phytother Res"},{"key":"6205_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.biopha.2016.10.061","volume":"84","author":"MT Jalali","year":"2016","unstructured":"Jalali MT, Mohammadtaghvaei N, Larky DA. Investigating the effects of capparis spinosa on hepatic gluconeogenesis and lipid content in streptozotocin-induced diabetic rats. Biomed Pharmacother. 2016;84:1243\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2016.10.061.","journal-title":"Biomed Pharmacother"},{"key":"6205_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5805398","author":"A Mahmoudi","year":"2022","unstructured":"Mahmoudi A, Moallem SA, Johnston TP, Sahebkar A. Liver protective effect of fenofibrate in NASH\/NAFLD animal models. PPAR Res. 2022. https:\/\/doi.org\/10.1155\/2022\/5805398.","journal-title":"PPAR Res"},{"issue":"11","key":"6205_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.lfs.2006.03.021","volume":"79","author":"Y Zou","year":"2006","unstructured":"Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 2006;79(11):1100\u20137. https:\/\/doi.org\/10.1016\/j.lfs.2006.03.021.","journal-title":"Life Sci"},{"issue":"1","key":"6205_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2003.12.031","volume":"92","author":"W Li","year":"2004","unstructured":"Li W, Zheng H, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004;92(1):1\u201321. https:\/\/doi.org\/10.1016\/j.jep.2003.12.031.","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"6205_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11655-011-0810-3","volume":"17","author":"PK Prabhakar","year":"2011","unstructured":"Prabhakar PK, Doble M. Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin J Integr Med. 2011;17(8):563. https:\/\/doi.org\/10.1007\/s11655-011-0810-3.","journal-title":"Chin J Integr Med"},{"issue":"3","key":"6205_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11655-010-0674-6","volume":"17","author":"L-x Yang","year":"2011","unstructured":"Yang L-x, Liu T-h, Huang Z-t, Li J-e, Wu L-l. Research progress on the mechanism of single-Chinese medicinal herbs in treating diabetes mellitus. Chin J Integr Med. 2011;17(3):235\u201340. https:\/\/doi.org\/10.1007\/s11655-010-0674-6.","journal-title":"Chin J Integr Med"},{"issue":"1","key":"6205_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-020-05200-4","volume":"13","author":"R Akbari","year":"2020","unstructured":"Akbari R, Yaghooti H, Jalali MT, Khorsandi LS, Mohammadtaghvaei N. Capparis spinosa improves the high fat diet-induced non-alcoholic steatohepatitis in rats: the possible role of FGF21. BMC Res Notes. 2020;13(1):1\u20137. https:\/\/doi.org\/10.1186\/s13104-020-05200-4.","journal-title":"BMC Res Notes"},{"issue":"1","key":"6205_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3803\/EnM.2017.32.1.6","volume":"32","author":"Y-A Moon","year":"2017","unstructured":"Moon Y-A. The SCAP\/SREBP pathway: a mediator of hepatic steatosis. Endocrinol Metab. 2017;32(1):6\u201310. https:\/\/doi.org\/10.3803\/EnM.2017.32.1.6.","journal-title":"Endocrinol Metab"},{"issue":"11","key":"6205_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3109\/00365521.2011.613945","volume":"46","author":"MJ Frederico","year":"2011","unstructured":"Frederico MJ, Vitto MF, Cesconetto PA, Engelmann J, De Souza DR, Luz G, et al. Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. Scand J Gastroenterol. 2011;46(11):1381\u20138. https:\/\/doi.org\/10.3109\/00365521.2011.613945.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"6205_CR20","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/oby.22559","volume":"27","author":"RJ Perry","year":"2019","unstructured":"Perry RJ. Novel strategies to treat hepatic steatosis and steatohepatitis. Obesity. 2019;27(9):1385\u20137. https:\/\/doi.org\/10.1002\/oby.22559.","journal-title":"Obesity"},{"issue":"6","key":"6205_CR21","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/hep.30097","volume":"68","author":"L Goedeke","year":"2018","unstructured":"Goedeke L, Bates J, Vatner DF, Perry RJ, Wang T, Ramirez R, et al. Acetyl-CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents. Hepatology. 2018;68(6):2197\u2013211. https:\/\/doi.org\/10.1002\/hep.30097.","journal-title":"Hepatology"},{"key":"6205_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/952734","author":"JP Hardwick","year":"2009","unstructured":"Hardwick JP, Osei-Hyiaman D, Wiland H, Abdelmegeed MA, Song B-J. PPAR\/RXR regulation of fatty acid metabolism and fatty acid. PPAR Res. 2009. https:\/\/doi.org\/10.1155\/2009\/952734.","journal-title":"PPAR Res"},{"issue":"18","key":"6205_CR23","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"6205_CR24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","volume":"65","author":"A Montagner","year":"2016","unstructured":"Montagner A, Polizzi A, Fouch\u00e9 E, Ducheix S, Lippi Y, Lasserre F, et al. Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut. 2016;65(7):1202\u201314. https:\/\/doi.org\/10.1136\/gutjnl-2015-310798.","journal-title":"Gut"},{"issue":"1","key":"6205_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1440-1746.2006.04819.x","volume":"23","author":"YS Seo","year":"2008","unstructured":"Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, et al. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. J Gastroenterol Hepatol. 2008;23(1):102\u20139. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04819.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"6205_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12864-018-4834-3","volume":"19","author":"A Montserrat","year":"2018","unstructured":"Montserrat A, Sugahara G, Hooiveld GJ, Ishida Y, Tateno C, Kersten S. The whole transcriptome effects of the PPAR\u03b1 agonist fenofibrate on livers of hepatocyte humanized mice. BMC Genomics. 2018;19(1):443. https:\/\/doi.org\/10.1186\/s12864-018-4834-3.","journal-title":"BMC Genomics"},{"issue":"2","key":"6205_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/tox.22511","volume":"33","author":"LB Jeng","year":"2018","unstructured":"Jeng LB, Velmurugan BK, Hsu HH, Wen SY, Shen CY, Lin CH, et al. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells. Environ Toxicol. 2018;33(2):234\u201347. https:\/\/doi.org\/10.1002\/tox.22511.","journal-title":"Environ Toxicol"},{"issue":"3","key":"6205_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367\u201379. https:\/\/doi.org\/10.1503\/cmaj.1040752.","journal-title":"CMAJ"},{"issue":"2","key":"6205_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3892\/etm.2012.575","volume":"4","author":"Z Tian","year":"2012","unstructured":"Tian Z, Liu H, Su X, Fang Z, Dong Z, Yu C, et al. Role of elevated liver transaminase levels in the diagnosis of liver injury after blunt abdominal trauma. Exp Ther Med. 2012;4(2):255\u201360. https:\/\/doi.org\/10.3892\/etm.2012.575.","journal-title":"Exp Ther Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06205-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-022-06205-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06205-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T20:00:49Z","timestamp":1664827249000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-022-06205-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6205"],"URL":"https:\/\/doi.org\/10.1186\/s13104-022-06205-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"26 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Committee of Research Center & Experimental Animal House, Ahvaz Jundishapur University of Medical Sciences. All experiments and methods were performed following relevant guidelines and regulations. Our study was performed according to ARRIVE guidelines. This regulatory body approved all experimental procedures involving animals prior to initiating the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}